BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2620910)

  • 1. Unique bioactivation of tiazofurin--studies with resistant cells.
    Kuttan R
    Indian J Biochem Biophys; 1989 Jun; 26(3):160-5. PubMed ID: 2620910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tiazofurin is phosphorylated by three enzymes from Chinese hamster ovary cells.
    Saunders PP; Spindler CD; Tan MT; Alvarez E; Robins RK
    Cancer Res; 1990 Sep; 50(17):5269-74. PubMed ID: 2143686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical consequences of resistance to tiazofurin in human myelogenous leukemic K562 cells.
    Jayaram HN; Zhen W; Gharehbaghi K
    Cancer Res; 1993 May; 53(10 Suppl):2344-8. PubMed ID: 8097964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiazofurin metabolism in human lymphoblastoid cells: evidence for phosphorylation by adenosine kinase and 5'-nucleotidase.
    Fridland A; Connelly MC; Robbins TJ
    Cancer Res; 1986 Feb; 46(2):532-7. PubMed ID: 3000575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of resistance to 6-aminonicotinamide.
    Saunders PP; Muhs MA; Arimilli S
    Anticancer Res; 1996; 16(2):843-8. PubMed ID: 8687139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.
    Carney DN; Ahluwalia GS; Jayaram HN; Cooney DA; Johns DG
    J Clin Invest; 1985 Jan; 75(1):175-82. PubMed ID: 2856924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Action of 2-beta-d-Ribofuranosylthiazole-4-carboxamide (tiazofurin) in Chinese hamster ovary and variant cell lines.
    Saunders PP; Kuttan R; Lai MM; Robins RK
    Mol Pharmacol; 1983 Mar; 23(2):534-9. PubMed ID: 6188036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of resistance to tiazofurin in hepatoma 3924A.
    Jayaram HN; Pillwein K; Lui MS; Faderan MA; Weber G
    Biochem Pharmacol; 1986 Feb; 35(4):587-93. PubMed ID: 2868729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tiazofurin: molecular and clinical action.
    Weber G; Prajda N; Abonyi M; Look KY; Tricot G
    Anticancer Res; 1996; 16(6A):3313-22. PubMed ID: 9042306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical mechanisms of resistance to tiazofurin.
    Jayaram HN
    Adv Enzyme Regul; 1985; 24():67-89. PubMed ID: 3835825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of cultured Lewis lung carcinoma cell lines to tiazofurin.
    Finlay GJ; Ching LM; Wilson WR; Baguley BC
    J Natl Cancer Inst; 1987 Aug; 79(2):291-6. PubMed ID: 3474463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of inosinate dehydrogenase.
    Kuttan R; Saunders P
    Biochem Int; 1987 Feb; 14(2):211-8. PubMed ID: 2883976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity.
    Cooney DA; Jayaram HN; Glazer RI; Kelley JA; Marquez VE; Gebeyehu G; Van Cott AC; Zwelling LA; Johns DG
    Adv Enzyme Regul; 1983; 21():271-303. PubMed ID: 6152729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of action of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide). VI. Biochemical and pharmacological studies on the degradation of thiazole-4-carboxamide adenine dinucleotide (TAD).
    Ahluwalia GS; Cooney DA; Marquez VE; Jayaram HN; Johns DG
    Biochem Pharmacol; 1986 Nov; 35(21):3783-90. PubMed ID: 2877671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide--V. Factors governing the response of murine tumors to tiazofurin.
    Ahluwalia GS; Jayaram HN; Plowman JP; Cooney DA; Johns DG
    Biochem Pharmacol; 1984 Apr; 33(8):1195-203. PubMed ID: 6143562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I evaluation and pharmacokinetics of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193).
    Melink TJ; Von Hoff DD; Kuhn JG; Hersh MR; Sternson LA; Patton TF; Siegler R; Boldt DH; Clark GM
    Cancer Res; 1985 Jun; 45(6):2859-65. PubMed ID: 3986813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo antiproliferative activity of IPCAR, a new pyrazole nucleoside analog.
    Pani A; Marongiu ME; Pinna E; Scintu F; Perra G; Montis AD; Manfredini S; La Colla P
    Anticancer Res; 1998; 18(4A):2623-30. PubMed ID: 9703919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism.
    Sokoloski JA; Sartorelli AC
    Mol Pharmacol; 1985 Dec; 28(6):567-73. PubMed ID: 2867464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot GJ; Jayaram HN; Lapis E; Natsumeda Y; Nichols CR; Kneebone P; Heerema N; Weber G; Hoffman R
    Cancer Res; 1989 Jul; 49(13):3696-701. PubMed ID: 2567208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of tiazofurin to enhance the metabolism and cytotoxic activities of analogues of guanine, guanosine, and deoxyguanosine.
    Saunders PP; Tan MT; Spindler CD; Robins RK
    Cancer Res; 1987 Feb; 47(4):1022-6. PubMed ID: 3802087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.